Back to trial details

Intake questionnaire

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Applying to University of Chicago · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Estrogen-receptor-positive Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?